Für diesen Artikel ist leider kein Bild verfügbar.

Cancer Chemotherapy and Biotherapy

Principles and Practice

Bruce A. Chabner, Dan Longo (Herausgeber)

Buch | Hardcover
1000 Seiten
2005 | 4th Revised edition
Lippincott Williams and Wilkins (Verlag)
978-0-7817-5628-0 (ISBN)
176,95 inkl. MwSt
zur Neuauflage
  • Titel erscheint in neuer Auflage
  • Artikel merken
Zu diesem Artikel existiert eine Nachauflage
Organized by drug class, the book provides the latest information on all drugs and biological agents - their mechanisms of action, interactions with other agents, toxicities, side effects, and mechanisms of resistance. It also explains the rationale for use of drugs in specific schedules and combinations.
Updated to include the newest drugs and those currently in development, this Fourth Edition is a comprehensive reference on the preclinical and clinical pharmacology of anticancer agents. Organized by drug class, the book provides the latest information on all drugs and biological agents--their mechanisms of action, interactions with other agents, toxicities, side effects, and mechanisms of resistance. The authors explain the rationale for use of drugs in specific schedules and combinations and offer guidelines for dose adjustment in particular situations. This edition provides expanded coverage of monoclonal antibodies, molecularly targeted drugs, vaccines, cell based therapies, growth factors, and pharmacogenetics.

    Clinical Strategies Bruce Chabner Preclinical aspects of Cancer Drug Discovery Ed Sausville, Paula Krosky, Melinda Hollingshead, Robert Shoemaker Pharmacokinetics Jerry Collins Infertility Angela Bradbury, Richard Schilsky Carcinogenesis Larry Blaszkowsky Antifolates Carmen Allegra, Brian Monahan Five Fluoropyrimidine Jean Grem Cytidine Analogues David Ryan Purine Analogues Kenneth Hande Hydroxyurea Bruce Chabner Antimicrotuble Agents Eric Rowinsky Alkylating Agents / Clinical & High Dose Roy Jones, Ken Tew Nonclassical Agents Henry Friedman Platinum Analogues Ed Reed Bleomycin Bruce Chabner Antibiotics Kees Nooter, Jaap Verweij, Edwin Willems Topo I: Inhibitors Alex Sparreboom, William Zamboni Topo II: Anthracyclines Jim Doroshow Topo II: Epipodophylotoxins Yves Pommier, Francios Goldwasser L-Asparaginase Bruce Chabner Pharmacology of CNS Agents Jeff Supko FDA Approval Thomas Roberts Catheter and Complications David Kuter, Rachel Rosovsky Pharmacogenetics Robert Diasio, Jeanne Fourie New Agents Louise Grochow Bisphosphonates Matthew Smith Thalidomide Paul Richardson Inhibitors of Tumor Angiogenesis William Gradishar, Anaadriana Zakarija Proteosome Inhibitors Owen O'Connor Molecular Targeted Drugs - Growth Factor Receptor Inhibitors Jeff Clark Monoclonal Antibody Therapies David Scheinberg Interferon Danield Linder, Earnest Borden Adoptive Therapies Carl June Vaccines Glenn Dranoff Hematopoietic Growth Factors William Petros Interleukins Gheath Alatrash, Ronald Bukowski, James Finke, Charles Tannenbaum Hormonal Therapy for Breast Cancer and Prostate Peter Lebowitz, Sandra Swain, Steven Balk

Erscheint lt. Verlag 1.11.2005
Zusatzinfo 134
Verlagsort Philadelphia
Sprache englisch
Maße 216 x 280 mm
Gewicht 2179 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Onkologie
ISBN-10 0-7817-5628-6 / 0781756286
ISBN-13 978-0-7817-5628-0 / 9780781756280
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Hannes Leischner

Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
27,00

von Stein Husebø; Gebhard Mathis; Eva Katharina Masel

Buch | Softcover (2023)
Springer (Verlag)
49,99